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1. Introduction
Noninvasive imaging plays a central role in the diagnosis of heart failure, assessment of
prognosis, and monitoring of therapy. Cardiovascular magnetic resonance (CMR) offers a
comprehensive assessment of heart failure patients and is now the gold standard imaging
technique to assess myocardial anatomy, regional and global function, and viability. Fur‐
thermore, it allows assessment of perfusion and acute tissue injury (edema and necrosis),
whereas in nonischemic heart failure, fibrosis, infiltration, and iron overload can be detected
[1]. The American College of Cardiology/American Heart Association have recently updated
their guidelines for imaging techniques used to assess patients with HF [2]. According to it,
two-dimensional echocardiography is currently the imaging modality most commonly used
in clinical practice to meet the ACCF/AHA requirements. It provides a good general assess‐
ment of LV function but is limited in patients with poor acoustic windows, it requires geo‐
metric assumptions in quantifying global LV systolic function, and its ability to provide
specific tissue characterization is modest. CMR is the gold standard to LV and RV global
and regional dysfunction, dilation, viability and what is the underlying etiology of HF. CMR
makes it particularly well suited to studying the RV, which is difficult to assess with echo‐
cardiography.
The CE-MARC study [3,4] defines the role of Cardiac MR: 752 patients with suspected heart
disease were recruited and scheduled for MR and SPECT as well as for an X-ray coronary
angiogram used as the reference standard. Angiography identified 39% of the patients with
CAD. Cardiac MR had a sensitivity and specificity of 86.5% and 83.4%, respectively. In com‐
parison, SPECT delivered a sensitivity and specificity of 66.5% and 82.6 %, respectively. Via‐
bility/post-myocardial infarction scarring can be described with unprecedented resolution,
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and highly specific patterns of fibrosis and scarring have been described for many nonische‐
mic cardiomyopathic processes. DE-CMR appears to offer advantages in detecting small or
subendocardial infarcts with high accuracy and is well validated. Late studies showed that
the sensitivity of DE-CMR increased with increasing gadolinium dose, reaching 99% and
94% in acute and chronic MI, respectively. These surveys have shown that unrecognized
MIs are common, comprising as many as 40% to 60% of all MIs.
Nearly one-half of HF patients have abnormalities in diastolic function with preserved ejec‐
tion fraction CMR can assess diastolic function in several ways. In an analogous manner to
echocardiography, MR tagging is a sophisticated method for quantitative analysis of region‐
al systolic and diastolic function.
2. Background
Cardiac MR is increasingly becoming the modality of choice in the diagnosis of coronary
and cardiac disease. The aim of this guide is to cover the most frequent conditions encoun‐
tered, highlight technical issues, differential diagnoses, and the most common pitfalls found
when diagnosing patients.
Cardiovascular disease is the most frequent cause of mortality in the developed world. Al‐
though diverse, many techniques exist for diagnosing cardiac diseases, and it is frequently
necessary to request several tests to reach a conclusive diagnosis. Magnetic resonance (MR)
is a well tolerated and safe technique, which is currently available in a majority of hospitals.
This technique makes it possible in a single exploration to study the anatomy of the heart,
allowing qualitative, semi-quantitative, and quantitative assessments to be made of the pa‐
rameters of cardiac anatomy and function. It provides information of cardiac and vascular
anatomy and function in complex congenital and acquired cardiopathies. With the adminis‐
tration of intravenous contrast, it also enables us to visualize the extent of ischemic cardio‐
pathies and assess myocardial viability. As such, cardiac magnetic resonance is emerging as
one of the most promising techniques for the study of congenital and acquired cardiac path‐
ology.
According to the American College of Cardiology [1], the proposed indications for CMR
Imaging in patients with Heart Failure are:
• Serial assessment of biventricular structure, size, and function (anatomy, LV/RV volumes,
global and regional systolic function, mass)
• Evaluation of native and prosthetic cardiac valves (planimetry of stenotic disease, estima‐
tion of peak stenotic velocities and gradients, quantification of regurgitant disease)
• Evaluation of cardiac masses, differentiation between tumour and thrombus
• Evaluation of great vessels and pulmonary veins
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• Determination of the location and extent of acute (including no-reflow regions) and
chronic myocardial necrosis
• Viability assessment before revascularization (LGE or low-dose dobutamine)
• Determination of the area at risk in patients with acute myocardial infarction and the sal‐
vageable area post-revascularization with percutaneous coronary intervention
• Identification of the presence and quantification of the extent of inducible ischemia (vaso‐
dilator perfusion or high-dose dobutamine stress CMR)
• Evaluation of suspected anomalous coronary origins (MR coronary angiography)
• Differentiation of ischemic versus non-ischemic cardiomyopathy
• Evaluation of myocarditis
• Evaluation of specific cardiomyopathies (in vivo tissue characterization)
• Dilated cardiomyopathy
• Hypertrophic cardiomyopathy
• Arrhythmogenic right ventricular cardiomyopathy
• Cardiac amyloidosis
• Cardiac sarcoidosis
• Anderson-Fabry disease
• Iron overload cardiomyopathy
• Left ventricular noncompaction
• Other less common diseases (e.g., Chagas disease, endomyocardial fibrosis, Churg-
Strauss syndrome, and so on)
• Assessment of mechanical dyssynchrony before resynchronization therapy
• Patients with technically limited images from echocardiogram
• Discordant information that is clinically significant from prior tests
3. A survival guide to cardiac MRI
3.1. Protocol
a. Sequences: SE (black blood), gradient ECHO: CineMRI, perfusion, viability, flow quan‐
tification, motion tagging, and others.
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b. Planes: SA, 2CH, 3CH, 4CH, inflow and outflow.
c. How to review:
• Structure (size, thickness)
• Function (motility, volumes, EF, cardiac output)
• Valves (morphology, flow)
• Ischemia: T2 STIR, perfusion first pass and stress, viability (DHE)
3.2. Sequences
BLACK BLOOD: SE (Spin echo) is the most suitable sequence to analyze the morphology of
the heart and great vessels. The blood is black and fat is white. Variations are fast (or turbo).
Spin echo (FSE or TSE) allows the acquisition of an entire image in a single heartbeat.
Figure 1. Protocol cardiac MR. Timeline and potential components of a multitechnique CMR examination for Cardiac
imaging. 2D=2-dimensional; 3D= 3-dimensional; CMR= cardiovascular magnetic resonance; MI= myocardial infarction;
MRA= magnetic resonance anglography; SNR= signal-to-nolse ratio.
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Figure 2. T1 Black Blood image using SENSE aortic outflow plane: coarctation of the aorta.
WHITE BLOOD: GE (Gradient echo). Blood and fat appear white. Variations: b-SSFP (bal‐
anced Steady-State Free Precession Imaging), FLASH and velocity mapping. b-SSFP cine se‐
quence can also be applied 2D (single shot), as a real time technique (does not require breath
holding or ECG triggering) and 3D volume scan.
Figure 3. b-SSFP: 2 CH short axis: measure thickness RV and LV. Normal thickness RV 3mm LV 10-12mm.
Figure 4. b-SSFP cine (diastole and systole): Global and segment analysis of movement and thickness.
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It is used to analyze global and regional cardiac function, detecting abnormal flow, such as
jets from stenoses of the valves or insufficiency, to study flows and quantify the degree of
stenosis and regurgitation, to quantify Qp:Qs between pulmonary and systemic flow, and is
also useful in detecting congenital malformations. CineMR: To analyze the contractility of
the heart wall. Analysis is performed for each segment (hypokinesia, akinesia, dyskinesia):
There must also be evidence of wall thickening.
We can see jets (turbulent flow) in the valves or from the outflow of left or right ventricles.
- AV valves:
• Insufficiency or regurgitation, if the flow of the jet is directed into the ventricles.
• Stenosis: the flow of the jet originates from inside the ventricles.
- Aortic and pulmonary valves:
• Insufficiency, the flow of the jet is directed into the ventricles
• Stenosis: the origin of the jet comes from outside the ventricles from the vessels.
 
Figure 5. Plane aortic valve (bicuspide aortic valve) and plane outflow LV with yet of aortic insufficiency
Figure 6. Q-Flow magnitude and phase encoding (velocity mapping): bicuspid aortic valve with regurgitation
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VELOCITY MAPPING (Flow velocity mapping):
• Detect and quantify peak velocity in valvular stenosis.
• Calculate overflow in a mayor vessel through the cardiac cycle
• Quantification in regurgitation or valvular incompetence.
• Confirm abnormal chamber communication and the ratio of pulmonary to systemic flow
in shunts, such as septal defects.
• Determine the average velocity: The operator selects the plane and sets a maximal encoding
velocity (VENC), the initial VENC used is an approximation upper of the velocity expected.
INVERSION RECOVERY TECHNIQUE AND CONTRAST ENHANCEMENT MR (CE-MR):
Uses a pre-pulse to create high T1 tissue contrast to visualize infarct imaging (black myocar‐
dium), compound of gadolinium (Gd-DTPA) to detect insufficient perfusion in first pass,
followed by a delayed DHE to detect scar or inflammatory changes (white myocardium in
infarct, myocarditis and infiltrative diseases.) Stress MR can be obtained using adenosine or
dobutamine as chemical stressors.
Furthermore, this can be used to evaluate cardiovascular physiology and anatomy, charac‐
terize tissues, and vascular angiography.
Figure 7. Early Enhancement Perfusion Short Axis SENSE (TR: 2, TE: 1)
Figure 8. DHE Late contrast enhancement 8 minutes after injection of Gadolinium. Apical enhancement: scar of inferi‐
or infarction.
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OTHERS:
• Contrast-enhanced MR angiography: study of aortic aneurism and dissection, congenital
anomalies of great vessels, vasculitis evaluation, central thoracic veins, pulmonary artery
anatomy, postsurgical follow-up and contraindications to computed tomography
• TAGGING IMAGING: Measurement the contractility of myocardium; T2 STIR: In edema,
and T2* for quantification of haemochromatosis; Sequences fat suppression (SPIR), etc
3.3. Planes in cardiac imaging
Figure 9. Protocols for cardiac imaging: a,b,c. Rapid pilot scans in the 3 orthogonal planes (axial, coronal and sagittal)
in a breath-hold, FSE 1 imaging per cardiac cycle; d. Anatomical coverage from the diaphragm up to the thoracic inlet
into the 3 orthogonal planes.
3.3.1. Specific standard cardiac planes (intrinsic) with GE cines and SE sequences
From the axial plane:
• 2CH (2 chamber) and LA (ventricular long axis) to acquire HA (horizontal long axis), in‐
flow (mitral plane) and outflow (aortic plane)
• SA (Short Axis): inflow HA and 4CH (4 chambers).
• Real 4CH: from SA (short axis) between papillary muscles and inflow LA (mitral valve)
• 3CH (3 chambers): from LA and perpendicular aortic valve.
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Figure 10. Ventricles size and wall thickness measurement procedure. First and second images: 2CH LA apex 3mm, SA
lateral wall and septum 10-12 mm; Third image: 4CH LV size 50mm
3.3.2. Target CMR with additional planes and sequences, such inversion recovery
Sagittal, coronal or oblique planes, LV and RV outflow, valves plane, etc.
3.4. Topics to review
3.4.1. Structure
Size is measured in 4CH in systole and in diastole. Size of chambers in systole and diastole
(ant-post): LV 50mm, RV 32mm and LA (left atrium) inferior a 40mm.
The thickness of the wall is measured (end of diastole) in SA (basal and middle) and LA (ap‐
ical). Left ventricle 10-12mm (< 15mm hypertrophy) and right ventricle > 6mm.
3.4.2. Function
CINE SA and LA:
REGIONAL FUNCION:
Visual assessment of wall motion patterns using cardiac short axis b-SSFP cine: End- diastol‐
ic, mid- diastolic and end-systolic.
• Normokinesia: normal wall motion.
• Hypokinesia: Decreased wall motion.
• Akinesia: absent wall motion.
• Dyskinesia: wall motion in the opposite direction.
• Hyperkinesia: increased wall motion.
GLOBAL FUNCION:
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CINE MRI SA and LA using b-SSFP is probably the best technique to quantify ventricu‐
lar volumes, function, and mass.  The most commonplace is the Simpson method: draw‐
ing  epicardial  and  endocardial  borders  of  LV  in  systole  and  diastole,  this  can  also  be
used for the RV.
The following items are to be analyzed:
• LV undergoes a circumferential and longitudinal ventricular shortening and an extensive
wall thickening during systole. The sequence allows the obtention of the ejection fraction
(EDV – ESV = SV (mL); SV/EDV = EF (%).
• Ventricular mass to be measured in diastole.
Male Female
LV RV LV RV
EDV (end diastolic volume) 77-195 88-227 52-141
ESV (end systolic volume) 19-72 23-103 12-51
SV (systolic volume) 51-133 52-138 33-97
EF (%)(ejection fraction) 56-78 47-74 56-87
Mass index (g/m2) < 113 < 36 < 95 < 33
Table 1. Parameters of ventricular function in the population.
3.4.3. Study valves
CINE: jet and direction. Stenosis: through chamber and regurgitation through proximal
chamber.
VELOCITY MAPPING: Imaging plane perpendicular to the vessel.
• Quantification volume in both ventricles in SA. N 1:1
• Quantitative velocity mapping: Flow measurement, LV and RV outputs quantification
and comparison with ascending aorta and pulmonary trucks.
• Ventricular function EF ejection fraction.
3.4.4. Study ischemia
- T2 STIR: Hyperintensity in edema. It could appear in acute infarct or myocarditis.
- PERFUSION:
• FIRST PASS or EGE (early Ga enhancement): ischemic areas no enhancement. Stress per‐
fusion with adenosine or dobutamine: Induced ischemia (revascularizable)
• VIABILITY or DHE (delayed enhancement) or LGE (late Ga enhancements) after 10-20
min Ga in interstitial space. This is present in an acute infarct because of edema and rup‐
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ture of the membrane, and in chronic infarcts due to scarring of the tissue. Necrosis (“The
White is dead”) is typically ischemic, and occurs within the endocardium or can be trans‐
mural, and extend across the entire wall.
- INVERSION RECOVERY TECHNIQUE AND CONTRAST ENHANCEMENT MR (CE-
MR). This uses a pre-pulse to create high T1 tissue contrast to visualize infarct imaging
(black myocardium) and chelats of gadolinium (Gd-DTPA) to detect damage in PERFU‐
SION in first pass and delayed at 10 mins DHE to detect scarring or inflammatory changes
(white myocardium in infarct, myocarditis, infiltrative diseases...). Also be can be used with
Stress MR using adenosine or dobutamine.
Table 2. Evaluation of CAD (Coronary artery disease) with cardiac MRI
 
Figure 11. SSFP Cine: enormous aneurism with thrombus in the wall. Huge dilatated LV 163ml/m2. Systolic dysfunc‐
tion FE 20%. On the right: GDHE apical and inferior aneurism (no enhancement) with apical thrombus. Transmural
inferior myocardium.enhancement suggest microvascular obstruction
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Figure 12. Types of DHE in ischemic cardiopathy: (1) Subendocardial infarction: enhancement only in endocardium
and thinness of wall; (2) Transmural infarction: enhancement all the thickness of the inferior wall; (3) No-reflow; (4)
Occlusive infarction.
“The no reflow phenomenon”: Early DHE 5-7mins could be transient: This pattern repre‐
sents a transmural infarction, in which the reperfusion was only partially successful, with a
residual lack of reperfusion at the tissue level. This can show evidence of important edema
or necrosis with microvascular damage, and predicts against a functional recovery.
Non-reperfused occlusive infarcts: DHE Peripheral enhancement surrounding a dark core of
non-perfused myocardium.
4. The top 10 cases
4.1. Ischemic cardiopathy
In patients with known or suspected myocardial infarction (MI), cardiovascular magnetic
resonance (CMR) provides a comprehensive, multifaceted view of the heart.
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Recent multicenter clinical trial indicates that delayed-enhancement cardiac magnetic reso‐
nance imaging (DE-CMR) is a well-validated, robust technique that can be easily imple‐
mented on scanners that are commonly available worldwide with an effectiveness that
clearly rivals the best available imaging techniques for the detection and assessment of acute
and chronic MI. When patients present with symptoms outside the usual diagnostic win‐
dow of cardiac troponins, DE-CMR may be especially useful. Moreover, because DE-CMR
can uniquely differentiate between ischemic and various nonischemic forms of myocardial
injury, it may be helpful in cases of diagnostic uncertainty, such as in patients with classical
features of MI, in whom coronary angiography does not show a culprit lesion. Even once a
diagnosis of MI has been made, CMR can also provide clinically relevant information such
as identifying residual viability, microvascular damage, stunning, and right ventricular in‐
farction. In addition, post-MI complications, including left ventricular thrombus and peri‐
carditis, are easily identified. Given that quantification of infarct size by DE-CMR is highly
reproducible, this technique may provide a useful surrogate end point for clinical trials with
appreciable reductions in sample size compared with alternative methods. [5]
Study of ischemia sequences
• T2 weighted STIR: edema-weighted imaging. Hyper intensity could appear in acute infarct
or myocarditis.
• CINE b-SSFP: motility: Hypokinesia dyskinesia of ischemic areas
• Perfusion: first pass of EGE (early Ga enhancement): ischemic areas no enhancement.
Stress perfusion with adenosine and dobutamine: Induced ischemia.
• Viability DHE (delayed enhancement) or LGE (late Ga enhancement) after 10-20 mins.
Gadolinium in interstitial space in acute infarct because of edema and rupture of mem‐
brane and in chronic infarct due to scarring, showing the extension of the scar.
Scarring less than 25% of the thickness of the wall (subendocardial), 25-50%, greater than
50% (transmural). This usually associates with thinning of the wall and is a prognosis factor
that predicts functional recovery after revascularization.
Patterns of ischemic enhancement
The distribution of DHE from ischemia is typically subendocardial to transmural. Differen‐
tial diagnosis with myocarditis: diffuse multifocal enhancement, often epicardial The mor‐
phology of an area of DHE is also relative to the longitudinal distribution of the blood
supply of the coronary artery.
• Inferior infarctions: area of enhancement basal and mid-ventricular myocardium. May ex‐
tend towards the infero-lateral RV right ventricular wall
• Lateral wall infarctions: mid ventricular and apical portions
• Anterior infarctions: antero-basal wall and may include the apex
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Imaging
Technique cardio
RM
Morphologic
correlation
Clinical
applications Normal Acute IAM Chronic IAM
Induced
Ischemia
Cine
Rest/stress (LDD)
Contractile
Function
LV Function
Ischemia/ viability Normal
Normal/
decrease
contractile
function
Normal/
decrease
contractile
function
Normal
decrease
with stress
Weighted T2 Myocardial edema
Tissue in risk
Inflammation
(swelling)
Perfusion first pass:
Rest and stress
Regional
myocardial flow
Myocardial
ischemia
Microvascular
obstruction
N. I.
Early enhancement
EHG
Normal
microvascular
No reflow.
Microvascular
obstruction
Late enhancement
DHE
Myocardial
necrosis/ fibrosis
Infarct size
Viability
Table 3. Ischemic cardiomyopathy differential diagnosis between normal, acute or chronic infarct and induced
ischemia (black circle: hypointensive; White circle: hyperintensive; N. I.: not indicated)
 
Figure 13. Ischemic cardiomyopathy. DHE. Enhancement inferior infarction: area of enhancement basal and mid-ven‐
tricular myocardium.
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 Figure 14. Cine b-SSFP Diastole and systole: apical aneurism (diskinetic area)
4.2. Dilated cardiopathy
The main differential diagnosis is between ischemic and non-ischemic dilated cardiopathies.
Non-ischemic: idiopathic, amyloidosis, haemochromatosis end stage, metabolic toxic alcohol
Figure 15. DHE: Chagas Disease. American trypanosomiasis. Severe LV dysfunction, heart failure and tachycardia MR
Ga: high signal of inflammation in infero-lateral wall of the LV.
Figure 16. SSFP systole: dilated four chamber hypokinesia
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 Figure 17. Ischemic dilated myocardiopathy: 2CH SA and 4CH Dilated chambers and DHE inf basal because of an infarct.
4.3. Hypertrophic MC
Criteria:
Morphological: measure diastolic myocardial thickness LV > 15mm, RV > 5mm in absence of
Hypertension, aortic stenosis, amyloidosis or pulmonary hypertension. Measure left chambers.
MR is used when a cardio echogram cannot determinate the severity and risk.
Functional: mitral valvulopathy, obstruction left ventricle outflow and motility dysfunction.
DHE: detect fibrosis and perfusion disorders as a prognosis factor. Non-enhanced is good
prognosis.
 
Figure 18. Cine b-SSFP Diastole and systole: Hypertrophic myocardiopathy. Measure diastolic myocardial thickness LV
> 15mm
4.4. RVAD (Right ventricle arrythmogenic dysplasia)
Etiology: inherence diseases (1:5000). A. D. Transmission variability. The diagnosis criteria
proposed by RVAD Task Force in 1994 are based on the presence of major and minor criteria
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encompassing structural, histologic, electrocardiographic, arrhythmic and genetic factors: 2
major criteria, 1 major plus 2 minor, or 4 minor. MR allows multiplanar evaluation of the
right ventricle (RV), enabling accurate morphologic and functional assessment.
• RV and outflow dilated
• Aneurisms
• Global systolic dysfunction
• Regional dysfunction contraction
• Fibro fatty transformation
Figure 19. b-SSFP sequences fat suppression, cine and DHE of a ADRV. Criteria: RV 129 ml/m2 global dysfunction of RV
(FE RV 29%), dyskinesia, saccular granulations, fibro fatty transformation and late enhancement of gadolinium (DHE).
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4.5. Restricted cardiopathy
Restrictive cardiomyopathies constitute a heterogeneous group of heart muscle conditions
that all present with the symptoms of heart failure, showing diastolic dysfunction with pre‐
served systolic function.
The majority of restrictive cardiomyopathies are secondary to a systemic disorder such as
amyloidosis, sarcoidosis, scleroderma, haemochromatosis, eosinophilic heart disease, or as a
result of radiation treatment. The more rare diagnosis of idiopathic restrictive cardiomyop‐
athy is supported only by the absence of specific pathology or endomyocardial biopsies.
The classic anatomical features of a restrictive cardiomyopathy are: small left ventricle (not
dilated) with marked atrial dilatation and normal systolic function in the absence of pericar‐
dial disease.
MRI can demonstrate the underlying anatomical lesion:
• Pericardial thickening, though the presence of a pericardium or normal thickning does
not entirely exclude the possibility of constriction. The main differential diagnosis is with
constrictive pericarditis.
• Additional imaging features such as abnormal right ventricular shape, vena cava dilata‐
tion, and paradoxical movement of the intraventricular septum, during operator guided
deep respiration.
• Characteristic tissues, especially the demonstration of interstitial or nodular fibrosis based
on the underlying etiology. In the presence of constrictive pericarditis from pericardial in‐
flammation, fibrosis or calcifications, diastolic expansion is impaired resulting in poor di‐
astolic ventricular filling, resulting in a characteristic type of diastolic impairment.
• Amyloidosis: Homogenous increased thickness of ventricular and atrial walls. The ven‐
tricular cavities are normal or reduced in size. Severe concentric hypertrophy of both nor‐
mal sized ventricles in absence of hypertension or valvular heart disease is suggestive of
amyloidosis. The atria are usually enlarged owing to the diastolic dysfunction and /or
valvular dysfunction due to amyloid deposition. Atrial septum usually > 6mm. Pleural
and epicardial effusions are frequent. Inhomogeneous enhancement, patchy, subepicar‐
dial or subendocardial, and irrespective of coronary territories.
The differential diagnosis from constrictive pericarditis may be necessary.
MR imaging can serve as a noninvasive examination for the definitive diagnosis of constric‐
tive pericarditis and can help distinguish between constrictive pericarditis and restrictive
cardiomyopathy on the basis of pericardial thickness. Mean thickness 1mm.
• The most frequent site of pericardial thickening is over the right ventricle. In Constrictive
pericarditis, the signal intensity of the thickened pericardium is similar or decreased com‐
pared with that of the myocardium.
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• Indirect findings of impaired right ventricular diastolic filling (e.g., dilatation of the inferi‐
or vena cava and right atrium) identified in constrictive pericarditis and restrictive cardio‐
myopathy.
Figure 20. b-SSFP and DHE in Amyloidosis: patchy, subepicardial or subendocardial enhancement irrespective of coro‐
nary territories.
Miocardiopathies
Etiology: Primary or secondary to systemic diseases. [6]
Cardiac MR is very useful in myocardiopathies (MC):
• Genetics: hypertrophic MC (MCH), RVDA arrhythmogenic dysplasia of the RV, non-com‐
pacted MC.
• Mixed: dilated MC (MCD), restrictive MC.
• Acquired: inflammatory MC (myocardytis), stress MC (apical ballooning: Tako-Tsubo):
transient apical dilatation and dysfunction.
4.6. Pericarditis and myopericarditis
Pericardial inflammation can be caused by infectious diseases viral/bacterial/tuberculosis/
fungal); can be manifestation of various systemic diseases (e.g. Rheumatoid arthritis, lupus
scleroderma, in patients with uremia, following an acute myocardial infarction, as a result of
radiation exposure, or idiopathic.
• Acute may result in diastolic heart failure
• Chronic: fibrosing pericardium ending in stiffening of the pericardium constricting the
heart.
Constrictive pericarditis is a thickening (greater than 4 mm), fibrotic and/or calcified pericar‐
dium constricting heart.
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Normal pericardial thickness is 2mm or less.
Myopericarditis is frequently associated with pericarditis. With a third of cases developing into
dilated myocardiopathy. Global dysfunction of myocardium with non coronary distribution.
Figure 21. A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy using
MR imaging. [7]
Figure 22. Miocarditis: SSFP apical hypokinesia and thrombus. DHE basal, medium and apical
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4.7. Valvular diseases
• Cardiac MR provides good functional information about both valvular stenosis and re‐
gurgitation, and allows accurate assessment of ventricular function and relevant cardiac
and vascular anatomy. Cardiovascular MR is the gold standard for non invasive imaging
of regurgitation: can image the regurgitant volume in any plane, and thus 3D apprecia‐
tion of the jets can be acquired. Furthermore, it can quantify the regurgitant volume and
regurgitant fraction, as well as ventricular function. Transthoracic echocardiography re‐
mains the most important and accessible, and easily performed, quantification of valvular
heart disease, measuring valvular stenosis and valve area. However this technique is less
accurate in quantifying valvular regurgitation with a semi quantitative assessment and
only provides an estimate of ventricular function. In addition, imaging planes may be re‐
stricted with this technique. X-ray–Angiography (AGF) has been regarded the gold stand‐
ard but the assessment of valvular regurgitation is both imprecise, inaccurate, and
invasive.
• Qualitative assessment of signal loss on cine MR images
• GE technique: For regurgitant lesions signal loss can be grades in a similar way to X-ray
AGF: grade 1 = signal loss close to the valve; grade 2 = signal loss extending into the prox‐
imal chamber; grade 3 = signal loss filling the whole of the proximal chamber; grade 4 =
signal loss in the receiving chamber throughout the relevant half of the cardiac cycle.
Quantitative assessment by measurement of ventricular volumes. MR is the gold standard
technique. Using a set of SA cuts covering the length of the ventricles, in combination with
Simpson`s rule, the stroke volumes of both right and left ventricle can be measured. There is
a 1:1 relationship between these stroke volumes; any discrepancy between the ventricular
volumes in a patient with regurgitation will identify the regurgitant volume.
• Quantitative assessment by phase-contrast velocity mapping can be applied in any direc‐
tion for flow quantification of RV and LV outputs can be compared from the proximal as‐
cending aorta and pulmonary trunk. The severity of the regurgitation fraction: 15-20%
mild, 20-40% moderate and >40% severe regurgitation.
• Valvular stenosis can be identified by signal loss in cine-MR. Velocity mapping is used to
establish an accurate peak velocity across the valve and to quantify the severity of the
stenosis. The mean velocity across caval veins and the mitral valve can be used to de‐
scribe the inflow curves for the A-V valves.
4.8. Cardiac masses
Cardiac mass may be a neoplasm or non-neoplasmic swelling, such as a thrombus
Cardiac tumors may be secondary with direct extension, venous, with lymphatic extension,
malignant primary tumors, or benign, such as mixoma. The most frequent mass found in
clinical practice is due to a thrombus, while the second most frequent is due to mixoma.
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 Figure 23. Aortic stenosis and tricuspid regurgitation.
 
Figure 24. Mixoma: b-SSFP pedunculated mass in LA with heterogeneous DHEg
Figure 25. b-SSFP and DHE hidatidic cyst in myocardium and liver.
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LOCATION TUMOR MR FINDINGS CHARACTERISTICS
INTRACAVITARY Myxoma
Oval, mobile, LA (left atrium)
heterogeneous
enhancement
Fosa ovalis
Thrombus LA, orejuela, ventricles in IAM Low signal in DHE
Valvular vegetations Irregular masses valvular orperivalvular Signal similar to thrombus.
Metastases Transvenous spread Continued spread Primarytumor
INTRAMURAL CHILDREN Rabdomioma Several masses similar signalto muscles Children with E.T
Fibroma
Solitary mass disturbing
anatomy. Ventricles.
Intramural
Low signal T2
INTRAMURAL ADULTS Metastases Pericardial effusion mass withenhancement Melanoma hight signal T1
Lipomatous hypertrophy
of the interatrial septum
Septum >2cm, high signal in
T1
Loose signal in fat suppression
sequences
Lipoma Epicardial or intramural highsignal in T1
Loose signal in fat suppression
sequences
Paraganglioma Well defined in atrial walls orseptum Light-bulb in T2
Epi or PERICARDIAL Metastases Pericardial effusion Direct spread of tumour
Pericardial cyst Well defined cyst noenhancement Signal liquid in all sequences
Hemangioma Multiple cysts withenhancement High signal in T1 y T2
Table 4. Differential diagnosis of cardiac masses by location [8]
4.9. Aortic diseases and great vessels
• MR is the non invasive method of choice for the assessing the great vessels of the thorax.
• MR angiography provides exquisite 3D imaging.
• Assessment of ventricular function and intracardiac anatomy may be important.
• Aortic aneurism: sinus of valsalva > 3.3cm; ascending aorta: mid > 3cm and distal > 2.4cm.
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Figure 26. Metastases of germinal tumor: eco and TC peduculated mass in RA. MR: SE and DHE with enhancement of
a large mass.
Figure 27. b-SSFP, cine SSFP, RM angiography and QFlow: Dilated ascending aortic with moderate aortic regurgita‐
tion. EF and % regurgitation
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Figure 28. Aortic aneurism: sinus of valsalva > 3.3cm, mid ascending aorta > 3cm and distal ascending aorta > 2.4cm
• Aortic coarctation: area of narrowing of the thoracic aorta in the region of inserction of the
arterial duct with or without additional abnormalities.
Figure 29. SE blackblood coartation.Volume-rendered 3D. AGF-MR:colateral vessel. Magnitude and velocity map: Bi‐
cuspid aortic valve (jet of aortic stenisis) and aortic coarctation after sugery
• Others:Aortic arch anomalies, interrupted aortic arch, vascular rings, aortic disection, ul‐
ceration and intramural hematoma, Marfan.
• Anomalous pulmonary veins (PV): anomalous pulmonary venous return or systemic ve‐
nous abnormalities.
4.10. Congenital diseases
Cardiac MR is increasingly becoming an important tool for the diagnosis and follow-up of
children and adult patients with congenital heart disease. Its main role is as an adjunct to
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echocardiography. MR can provide an accurate, non-invasive method of imaging for assess‐
ment of form (3D assessment of anatomy) and function, and is the best method for quantifi‐
cation of ventricular function and vascular flow. The use of (VENC) velocity-encoded-
phase-contrast MR allows accurate non invasive quantification of blood flow and pressure
gradients, Qp:Qs, and assessment of myocardial perfusion and coronary artery anatomy.
Best method for ventricular volumetry (in particular of the RV).
SEQUENTIAL SEGMENTAL ANALYSIS: the nomenclature of complex congenital diseases
is based in segmental analysis. Require description of atrial situs, atrio-ventricular connec‐
tions, and other associated lesions. Increasing ability to assess myocardial perfusion and cor‐
onary artery anatomy.
• ASD (Atrial septal defect) are the most common congenital heart defects detected in
adults. Cause left-to-right shunting at the atrial level. There are three types: Ostium se‐
cundum (80% of ASD), Ostium primum and sinus venous defect.
• AVSD atrio-ventricular septal defect. Partial with a defect of the atrial septum or com‐
plete with defect of atrial and ventricular septum there are also abnormalities of the AV
valves.
Figure 30. TGV: transposition great vessels after the Mustard procedure. SE black blood LA left atrium connection af‐
ter surgery. SSFP: RV anatomic (left functionally) dilated 145ml/m2, hypertrophic FE 60%. Anatomic LV dilated FE 50%
• TGV is the second-commonest cyanotic congenital heart diseases in the first year of life.It is
defined as ventriculoarterial discordance with an anterior aorta arising from de RV, and the
pulmoray artery arising from the LV.40% have a VSD and 30% subpulmonary stenosis
• VSD ventricular septal defect depends of the shunt volume the left sided heart failure and
pulmonary vascular disease. Quantification of left-to-right shunts using VENC MR as a non
invasive method. Perimembranous lesions make up 80% of VSD.20% muscular septum.
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• Congenital aortic supravalvular stenosis: area of narrowing of the thoracic aorta in the re‐
gion of inserction of the arterial duct. There are three types; hourglass, membranous and
diffuse coarctation.
Figure 31. b-SSFP SA outflow. Jet of tricuspid regurgitation Ventricular septal defect and hypertrophy of RV. Tetralogy
of Fallot: is the most common cyanotic congenital heart defect, caused by malalignment of the infundibular septum,
which leads to right ventricular outflow (RVOT) obstruction, a subaortic VSD (ventricular septal defect) with aortic
override, and right ventricular hypertrophy. The role of MR is assesment of postoperative complications besides accu‐
rate diagnosis.
Others: pulmonary atresia, double outlet RV, common arterial trunk, anomalous coronary
artery, etc.
5. Conclusion
Cardiovascular MR has become a revolutionary technique for the management of cardiac
disease. With new sequences the development of this technique has become very important
in the diagnosis and management of multiples cardiac diseases and conditions, comple‐
menting echocardiography and cardiac angiography.
It has become one of the most accurate techniques (the gold standard) in quantification vol‐
umes, mass, study of the right ventricle, and the most complete in the diagnosis of ischemic
diseases and congenital diseases. The development of the science in this area has widened
the indications and reduced exploration times. Cardiologists and Radiologists must work
closely together, and have a widespread knowledge of the most frequent cases and possible
differential diagnoses, with a clear understanding of MR sequences and their uses and limi‐
tations of this technique.
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